A Study To Assess The Efficacy And Safety Of Bismuth Tripotassium Dicitrate (De-Nol) In Combination With Pantoprazole And Pantoprazole Monotherapy In Treatment Of Subjects With Nonsteroidal Anti-Inflammatory Drugs (NSAID)-Induced Gastropathy
Stopped Internal reassessment of the medicinal product development strategy by Sponsor
Conditions
- NSAID-induced Gastropathy
Interventions
- DRUG: bismuth tripotassium dicitrate
- DRUG: pantoprazole
Sponsor
Astellas Pharma Europe B.V.